Pharmaceutical Technology
January 02, 2015
Global Market Report
39
1
Bio/pharmaceutical manufacturers in the UK face challenges in proving that their drugs are worth the price.
January 02, 2015
Troubleshooting
39
1
Risks associated with single-use technologies, such as product loss and sterility assurance, are magnified in the filling operation because of its closeness to the product in its final form. A thorough evaluation of the assembly design process, manufacture, and use can assist in identifying and mitigating these risks.
January 02, 2015
Packaging Forum
39
1
New materials and software modeling streamline the blister-package design process.
January 02, 2015
Peer-Reviewed Research
39
1
Tocophersolan or TPGS was developed 60 years ago as a water-soluble form of vitamin E. The author gives an overview of TPGS, including its interesting properties, examples found in the literature, and a brief summary of the regulatory status and marketed formulations.
January 02, 2015
Industry Leaders
39
1
Fred Miesowicz, chief operating officer of Argos Therapeutics, discusses the advantages and challenges of developing and manufacturing personalized immunotherapies.
January 02, 2015
Regulatory Watch
39
1
The European Commission’s new structure has sparked controversy about its allocation of responsibilities and the impact on the development and approval of new medicines.
January 02, 2015
Featured Content
39
1
Understanding and preventing protein aggregation is crucial to ensuring product quality and patient safety.
January 02, 2015
Inside Standards
39
1
In late 2014, standards organizations continued to work towards harmonization and securing drug safety.
January 02, 2015
Regulatory Watch
39
1
Manufacturers are under pressure to develop pipelines, promote quality, and justify pricing.
January 02, 2015
Product Spotlight
39
1
January 02, 2015
Featured Content
39
1
Changing dynamics of the pharmaceutical industry are driving demand.
January 02, 2015
Outsourcing Outlook
39
1
There are significant differences between small molecules and biologics fill/finish capacity.
January 02, 2015
Ask the Expert
39
1
Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses how to handle staff challenges to regulation requirements
January 02, 2015
Statistical Solutions
39
1
The choice of dilution schemes can minimize solution preparation errors.
January 02, 2015
From The Editor
39
1
New designations lead to faster drug approvals, but there is more work to be done.
January 02, 2015
Issue PDF
39
1
Click the title above to open the Pharmaceutical Technology January 2015 issue in an interactive PDF format.